5. We conclude that partial inhibition of gastric acid 1. Studies of Helicobacter pylori show that microbes can alter gastrin release. Lack of gastric acid (achlorhydria) causes hypergastrinaemia and allows bacteria to grow within the stomach. We speculated that the bacteria contribute to the rise in gastrin seen after acid inhibition, and tested the idea by comparing plasma gastrin levels during inhibition of acid secretion between germ-free and conventional rats.
Studies of Helicobacter pylori
show that microbes can alter gastrin release. Lack of gastric acid (achlorhydria) causes hypergastrinaemia and allows bacteria to grow within the stomach. We speculated that the bacteria contribute to the rise in gastrin seen after acid inhibition, and tested the idea by comparing plasma gastrin levels during inhibition of acid secretion between germ-free and conventional rats.
2. Matched germ-free and conventional rats ( n = 8 per group) received either vehicle (saline) or one of two doses of the histamine-H,-receptor antagonist loxtidine for 1 week. Gastrin was measured in cardiac blood by a specific r.i.a.
3. Plasma gastrin concentrations in germ-free and conventional rats were 59 f 11 pmol/l (meanf SEM) and 36 f 8 pmol/l, respectively, after vehicle, and 153 f 30 pmol/l and 181 k 27 pmol/l, respectively, after loxtidine at a dose of 10 mg day-' kg-', which partially inhibits acid secretion. Administration of loxtidine at a dose of 70 mg day-' kg-', which completely inhibits acid secretion, did not produce a s i m c a n t extra rise in plasma gastrin concentration in germ-free rats (178 f 11 pmol/l), but further elevated plasma gastrin concentrations to 2 7 8 f 2 6 pmol/l in conventional rats (P<O.O05 compared with germ-free rats).
4. Loxtidine produced a dose-dependent rise in the number of eosinophils in the gastric mucosa of conventional rats.
INTRODUCTION
Absence of gastric acid (achlorhydria) leads to hypergastrinaemia, which is important because it may lead to gastric carcinoid tumours in patients with gastric atrophy [l] and in rats during pharmacological suppression of acid secretion [2, 31. It is still not clear how a lack of acid increases gastrin release. There is evidence that a physiological reflex is involved in the rapid changes in gastric release which occur, for example, on acidification of the lumen during meal stimulation [4] . However, other responses, including the rise in gastrin on gastric neutralization in man, do not begin for several hours [4,5], which seems unusually slow for a physiological reflex.
Gastric acid is strongly antiseptic, but salivary and enteric bacteria proliferate in the stomach if it is neutral [6] . Gastrointestinal bacteria have many effects on epithelial function, including the stimulation of gastrin release [7] . We asked whether bacterial contribute to the rise in gastrin which occurs on the suppression of acid secretion, and tested this by comparing the effect of the histamine-H,-receptor antagonist loxtidine [3] on gastrin release in germ-free and conventional rats.
METHODS
Matched germ-free and conventional Lister hooded rats were anaesthetized with Hypnorm, and osmotic minipumps (Charles River, Margate, Kent, U.K.) were inserted subcutaneously. The pumps were filled to deliver either saline (150 mmol/l NaCI) or loxtidine at a dose of 10 or 70 mg day-' kg-'. These doses of loxtidine were chosen to give partial and complete suppression of acid secretion, respectively [3] . Each treatment was given to eight germfree rats (mean body weight 306 g; six male and two female) and eight sex-matched conventional rats (mean body weight 276 g). The animals were fed ad libitum and had constant access to water. After 1 week the animals were anaesthetized with pentobarbital, and then were killed by exsanguination from the heart.
Blood samples were collected into chilled tubes containing EDTA (2 mg/ml of blood). The plasma was separated and stored at -20°C. Gastrin was measured by ria. using antiserum G179 donated by Professor Bloom [7] .
Longitudinal sections of the posterior gastric wall, including the antrum and distal body, were fixed in neutral-buffered formalin and then embedded in paraffin wax. Sections (4 pm) were stained by haematoxylin and eosin, peroxidase, chromotrope 2R and Toluidine Blue. Examinations were performed without knowledge of the treatment. Where appropriate, cell populations were assessed formally by examination of the basal zones and inter-glandular compartments. For each specimen, 10-22 high-power fields were examined, using a 10 x 10 graticule.
Statistical analysis was by analysis of variance and ttests. Values of P< 0.05 were taken to be statistically significant. Results are given as means k SEM.
RESULTS

Gastrin (Table 1)
One-way analysis of variance showed a significant effect of loxtidine on gastrin in both germ-free (P= 0.001) and conventional ( P < O . O O l ) rats. On two-way analysis of variance, the difference in gastrin between germ-free and conventional rats was significant (P= 0.046), and there was a sigmficant interaction between bacterial status and dose (P= 0.02), indicating that bacterial status affected the change in gastrin produced by the drug. Further analysis by t-tests showed that the difference in gastrin between germ-free and conventional rats was signtficant only after the high dose of loxtidine (P = 0.0032). This was because the high dose produced a signtficant rise in gastrin above that obtained with the low dose in conventional ( P < 0.022), but not in germ-free (P = 0.44), rats.
Histology (Table 2)
Initial examination showed no evidence of active inflammation and no differences between groups in the mucosal thickness, or in the numbers of mononuclear or mast cells. However, some sections appeared to have an increase in the number of eosinophils in the basal region of the lamina propria. Formal morphometry confirmed that there were no differences in the numbers of neutrophils, lymphocytes, mononuclear cells or mast cells, but that there was a difference in the number of eosinophils.
One-way analysis of variance showed that there was no significant effect of the dose of loxtidine on eosinophil counts in the whole field, at the base of the gland or between glands in germ-free rats. However, in the conventional rats loxtidine significantly increased the number of eosinophils in all the regions scored ( P < 0.001). Two-way analysis of variance showed a highly significant effect on the dose of loxtidine (P<O.OOl), but no effect of microbial status. There was, however, a significant interaction effect between bacterial status and dose on the number of eosinophils (P<0.05). A similar effect was seen for the number of eosinophils at the base of the gland (effect of drug, P<O.OOl; interaction, P=O.O14) and between the glands (effect of drug, P = 0.002), except that there was no sigmficant interaction term for the latter. The results of t-tests are shown in Table 2 . In conventional rats loxtidine produced a highly sigmficant rise (P<O.OOOl) in the total eosinophil count from 13+ 1 (control) to 37 k 4 (high dose) cells/field. Germ-free rats showed a smaller rise from 2 1 & 3 to 28 & 3 cells/field, which was not significant ( P = 0.052). However, germ-free rats had higher numbers of eosinophils after control infusions than did conventional rats (P= 0.024 for total count).
DISCUSSION
The results of this study demonstrate for the first time that the presence of microbial flora contributes to the rise in gastrin that occurs when gastric acid secretion is inhibited [2, [8] [9] [10] . Conventional rats released more gastrin than germ-free rats during infusion of high-dose loxtidine. However, plasma gastrin concentrations were similar in conventional and germ-free rats after control infusions and during administration of loxtidine at a dose which partially inhibits acid secretion. Therefore the difference seen during complete suppression appears to have been specific, rather than due to a generalized tendency of germ-free rats to release less gastrin or to respond less to loxtidine. The idea that bacteria might affect gastrin release emanated partly from our finding that Helicobacter pylori increases gastrin release [7] , and partly from the slow time course of the rise in gastrin which occurs on gastric neutralization in fasting humans. A neutral pH eventually causes very high gastrin levels, but the rise does not begin for about 5 h [5] . Notably, this slow response in man requires continuous neutralization to become fully established. Patients with atrophic gastritis who secrete no acid at all have plasma gastrin levels about 30 times normal, whereas patients on long-term omeprazole, which keeps the stomach near-neutral for all but about 3 h/day, have gastrin levels which are only about four times normal [9-111. These slow effects contrast with other effects of pH on gastrin release, such as that of acidification on basal or meal-stimulated gastrin release, which occur within 30 min [4] as expected for a physiological reflex.
Our results appear to distinguish two ways in which suppression of acid secretion affects gastrin release on the basis of whether bacteria are needed or not. The low dose of loxtidine was chosen to allow some acid secretion. This elevated plasma gastrin levels in germ-free as well as in conventional animals, therefore presumably by a physiological reflex. This might correspond to the rapid response seen in man. The additional rise in gastrin produced by the high dose of loxtidine required the presence of bacteria, and bacteria could contribute to the slow response seen in man. This may explain its slow onset as well as the need for continuous neutralization.
Bacteria do survive during periods when the pH is above 4 during treatment with cimetidine, but overgrowth does not become established because the gastric lumen is sterilized by secretion of acid during the night [ 121.
Saliva contains about 1 000 000 organisms/ml [6] and about 1 litre is swallowed per day. Gastric acid normally kills these bacteria, so that fasting gastric juice is virtually sterile. Overgrowth during neutralization is initially with aerobes from saliva, and then with the anaerobes and facultative anaerobes normally present in the colon.
Bacteria can affect many aspects of gastrointestinal function. Some produce specific bio-active factors such as cholera toxin. Others alter gut function by metabolizing substances in the lumen, for example bacterial digestion of fibre in the hind gut affects growth of colonocytes [13] . Bacteria also affect the gut by provoking the release of inflammatory mediators [ 141, and Wyatt et al. [ 151 have described patients with elevated basal gastrin associated with non-H. pylon' gastritis. Histological examination of the rat gastric mucosa in the present study showed a dosedependent increase in eosinophils in the conventional rats but not in the germ-free rats, and a sigmficant interaction effect between the effects of bacterial status and dose on eosinophil count. Conventional rats had sigmficantly more eosinophils than germ-free rats during infusion of high dose, but not low-dose, loxtidine. Eosinophils are known to release the cytokine interleukin I [16] . Two other cytokines, interleukin II and y-interferon, have been shown to release gastrin from the isolated perfused canine stomach [ 171. Therefore it is possible that intra-epithelial eosinophils contributed to the effect of loxtidine on gastrin release in the presence of bacteria. Unexpectedly, after control infusions the germ-free rats had significantly more eosinophils in all regions of the lamina propria, as well as a trend towards higher plasma gastrin concentrations, compared with conventional rats. The reason for this is not clear.
Our results support the novel hypothesis that gastric bacterial overgrowth contributes to the massive hypergastrinaemia seen in the absence of acid. They are also consistent with the idea that gastric inflammatory cells may modulate gastrin release [15, 171 . This is of considerable importance, as excessive gastrin can cause hyperplasia of enterochromaffin cells and gastric carcinoid tumours [l-31. Understanding of the mechanism of hypergastrinaemia would allow a rational approach to control of these changes, which could include antimicrobial therapy, or the design of regimens to allow periodic acidification of the stomach to suppress bacteria. Further work in this area might allow greater suppression of gastric acid production, allowing superior ulcer healing without excessive rises in plasma gastrin concentrations.
